AbCellera Biologics Inc.
เพิ่มขึ้น

ABCL - +40% upside with 1:3 RR

Set-up nicely after a squeeze for a breakout and a mean reversion to the fibonacci retracement areas.

My target is 0.50 which is $4.24

However, based on analyst ratings the stock could do 400% in the next 12 months.
Chart PatternsTechnical IndicatorsTrend Analysis

และใน:

คำจำกัดสิทธิ์ความรับผิดชอบ